These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

63 related articles for article (PubMed ID: 29153305)

  • 1. Current practice of autologous hematopoietic progenitor cell mobilization in adult patients with multiple myeloma and lymphoma: The results of a survey from Turkish hematology research and education group (ThREG).
    Tekgündüz E; Demirkan F; Vural F; Göker H; Özdoğu H; Kiki İ; Aydoğdu İ; Kaynar L; Erkurt MA; Çağırgan S; Beşışık S; Dağdaş S; Koca E; Kadıköylü G; Gündüz E; Yılmaz M; Beköz H; Ural AU; Baştürk A; Arat M; Albayrak M; Öztürk E; Akyol A; Bolaman AZ; Nevruz O; Özkan HA; Özgür G; Altuntaş F
    Transfus Apher Sci; 2017 Dec; 56(6):804-808. PubMed ID: 29153305
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Autologous hematopoietic progenitor cell mobilization and collection in adult patients presenting with multiple myeloma and lymphoma: A position-statement from the Turkish Society of Apheresis (TSA).
    Tekgündüz E; Arat M; Göker H; Özdoğu H; Kaynar L; Çağırgan S; Erkurt MA; Vural F; Kiki İ; Altuntaş F; Demirkan F;
    Transfus Apher Sci; 2017 Dec; 56(6):845-849. PubMed ID: 29153306
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosimilar filgrastim (leucostim®) have similar efficacy in steady-state hematopoietic progenitor cell mobilization compared to original filgrastim (neupogen®) and lenograstim (granocyte®): A retrospective multicenter study.
    Kayıkçı Ö; Tekgündüz E; Kaya AH; Göker H; Aslan A; İskender D; Namdaroglu S; Tetik A; Koçubaba Ş; Altuntaş F
    Transfus Apher Sci; 2017 Dec; 56(6):832-835. PubMed ID: 29162397
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Current status of art mobilization in Myeloma.
    Sevindik OG; Korkmaz S; Altuntas F
    Transfus Apher Sci; 2017 Dec; 56(6):850-853. PubMed ID: 29174798
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The comparison of Filgrastim (Neupogen®), biosimilar filgrastim (Leucostim®) and Lenograstim (Granocyte®) as a first line peripheral blood stem cell mobilization strategy in autologous hematopoieitic stem cell transplantation: a single center experience from Turkey.
    Sivgin S; Karakus E; Kaynar L; Kurnaz F; Pala C; Keklik M; Zararsiz G; Solmaz M; Eser B; Cetin M; Unal A
    Transfus Apher Sci; 2013 Jun; 48(3):315-20. PubMed ID: 23611684
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Body mass index does not impact hematopoietic progenitor cell mobilization for autologous hematopoietic cell transplantation.
    Khouri J; Rybicki L; Majhail NS; Kalaycio M; Pohlman B; Hill B; Jagadeesh D; Dean R; Hamilton B; Sobecks R; Koo A; Liu H
    J Clin Apher; 2019 Dec; 34(6):638-645. PubMed ID: 31381194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autologous stem cell transplantation and stem cell mobilization kinetics in elderly patients with B cell non-Hodgkin lymphoma.
    Dogu MH; Çagirgan S; Ocakci S; Kaya AH; Ilkkilic K; Sanli NM; Kahraman S; Eren R; Tekgunduz E; Hacioglu S; Kaynar L; Erkurt MA; Altuntas F
    Transfus Apher Sci; 2017 Dec; 56(6):814-818. PubMed ID: 29153347
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blood progenitor cell (BPC) mobilization studied in multiple myeloma, solid tumor and non-Hodgkin's lymphoma patients after combination chemotherapy and G-CSF.
    Engelhardt M; Winkler J; Waller C; Lange W; Mertelsmann R; Henschler R
    Bone Marrow Transplant; 1997 Mar; 19(6):529-37. PubMed ID: 9181898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Poor autologous mobilization status does not impact on hematological recovery but affects outcome after allogeneic stem cell transplant for lymphoma and myeloma.
    Crocchiolo R; Chabannon C; El-Cheikh J; Esterni B; Lemarié C; Fürst S; Castagna L; Bouabdallah R; Ladaique P; Coso D; Schiano JM; Stoppa AM; Rey J; Ivanov V; Aurran T; Faucher C; Blaise D; Calmels B
    Leuk Lymphoma; 2013 Feb; 54(2):417-20. PubMed ID: 22702654
    [No Abstract]   [Full Text] [Related]  

  • 10. A feasible shortcut for the mobilization outcome: Steady state CD34 positive hematopoietic stem cells.
    Yüksel MK; Tekgündüz E; Sönmez C; Topcuoglu P; Yurtcu A; Demiriz I; Tetik A; Kayıkçı O; Cınarsoy M; Altuntaş F
    Transfus Apher Sci; 2012 Aug; 47(1):67-75. PubMed ID: 22658279
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Optimal mobilization method and CD34+ dose calculation for autologous PBSC transplant in myeloma patients: two important unresolved questions.
    Alegre A
    Bone Marrow Transplant; 2009 Apr; 43(8):593-5. PubMed ID: 19384344
    [No Abstract]   [Full Text] [Related]  

  • 12. Peripheral blood hematopoietic stem cell mobilization and collection efficacy is not an independent prognostic factor for autologous stem cell transplantation.
    Wang S; Nademanee A; Qian D; Dagis A; Park HS; Fridey J; Smith E; Snyder D; Somlo G; Stein A; Rosenthal J; Falk P; Kogut N; Palmer J; Gaal K; Kim Y; Bhatia R; Yuan S; Kay C; Weiss L; Forman S
    Transfusion; 2007 Dec; 47(12):2207-16. PubMed ID: 17714420
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization study of filgrastim (Neutromax) during autologous haematopoietic precursor transplantation for myeloma and lymphoma patients.
    Ferro HH; Juni M; Bello R; Vidal A; Diez RA; Pavlovsky S
    Transfus Apher Sci; 2009 Oct; 41(2):87-93. PubMed ID: 19699152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.
    Sheppard D; Tay J; Palmer D; Xenocostas A; Doulaverakis C; Huebsch L; McDiarmid S; Tinmouth A; Mallick R; Martin L; Birch P; Hamelin L; Allan D; Bredeson C
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):763-767. PubMed ID: 26643030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Poor mobilization of hematopoietic stem cells-definitions, incidence, risk factors, and impact on outcome of autologous transplantation.
    Wuchter P; Ran D; Bruckner T; Schmitt T; Witzens-Harig M; Neben K; Goldschmidt H; Ho AD
    Biol Blood Marrow Transplant; 2010 Apr; 16(4):490-9. PubMed ID: 19925876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel hematopoietic progenitor cell mobilization regimen, utilizing bortezomib and filgrastim, for patients undergoing autologous transplant.
    Abhyankar S; Lubanski P; DeJarnette S; Merkel D; Bunch J; Daniels K; Aljitawi O; Lin T; Ganguly S; McGuirk J
    J Clin Apher; 2016 Dec; 31(6):559-563. PubMed ID: 26939585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The costs of mobilisation and collection of peripheral blood stem cells in multiple myeloma and lymphoma in an European country: results from The Gruppo Italiano Trapianto Midollo Osseo (GITMO) and Società Italiana di Emaferesi e Manipolazione Cellulare (SIdEM) survey.
    Pierelli L; Berto P; Accorsi P; Milone G; Lopatriello S; Aiello A; Iacopino P; Olivieri A; Rambaldi A; Bosi A
    Transfus Apher Sci; 2013 Dec; 49(3):615-22. PubMed ID: 23973731
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence of Clostridium difficile-associated diarrhea before and after autologous peripheral blood stem cell transplantation for lymphoma and multiple myeloma.
    Arango JI; Restrepo A; Schneider DL; Callander NS; Ochoa-Bayona JL; Restrepo MI; Bradshaw P; Patterson J; Freytes CO
    Bone Marrow Transplant; 2006 Mar; 37(5):517-21. PubMed ID: 16435018
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of single-dose pegfilgrastim after chemotherapy for the mobilization of autologous peripheral blood stem cells in patients with malignant lymphoma or multiple myeloma.
    Kroschinsky F; Hölig K; Platzbecker U; Poppe-Thiede K; Ordemann R; Blechschmidt M; Oelschlaegel U; Schaich M; Hänel M; Bornhäuser M; Ehninger G
    Transfusion; 2006 Aug; 46(8):1417-23. PubMed ID: 16934080
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Autologous hematopoietic cell transplantation: an update for clinicians.
    Hamadani M
    Ann Med; 2014 Dec; 46(8):619-32. PubMed ID: 25211470
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.